We also tested this combination treatment in a PANC-1 xenograft mice model and found that it dramatically inhibited PANC-1 xenograft tumor growth (Fig. 6C–E) and AMPK activation (Fig. 6F). The gene discussed is PRKAA2; the disease is neoplasm.